[Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment]
- PMID: 3592453
[Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment]
Abstract
Central nervous system toxoplasmosis was diagnosed in 12 immunosuppressed patients, eleven of whom had AIDS. Fever (9/12), confusion (7/12) and focal neurological manifestations (6/12) were the main clinical signs. Lumbar puncture yielded abnormal cerebrospinal fluid in 6/6 cases. Cerebral computed tomographic scan abnormalities, homogenous (2/12) or ring-like (9/12) contrast-enhancing mass lesions and/or low density lesions (6/12), were present in all patients. Brain biopsy confirmed T. gondii infection in 7/8 cases. The combination pyrimethamine-sulfadiazine accounted for complete resolution (4/8) or partial improvement (4/8) in eight out of 12 patients. Mean duration of therapy was 6.5 months (1-21.5 months) in 11 patients. No relapse was observed. In three cases spiramycin was ineffective in the prevention of neurotoxoplasmosis.
Similar articles
-
Cerebral toxoplasmosis in patients with AIDS.Am Fam Physician. 1990 Mar;41(3):867-73. Am Fam Physician. 1990. PMID: 2407076 Review.
-
[Opportunistic Toxoplasma gondii infections].Arch Fr Pediatr. 1985 Dec;42 Suppl 2:949-51. Arch Fr Pediatr. 1985. PMID: 3833107 French.
-
[Cerebral toxoplasmosis in patients with AIDS].Arch Neurobiol (Madr). 1989;52 Suppl 1:121-6. Arch Neurobiol (Madr). 1989. PMID: 2637654 Spanish.
-
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.Am J Med. 1988 Jan;84(1):94-100. doi: 10.1016/0002-9343(88)90014-9. Am J Med. 1988. PMID: 3337134
-
Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.Clin Pharm. 1989 Feb;8(2):84, 87. Clin Pharm. 1989. PMID: 2645082 Review. No abstract available.
Cited by
-
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis.Pathog Glob Health. 2017 Feb;111(1):31-44. doi: 10.1080/20477724.2016.1273597. Epub 2017 Jan 16. Pathog Glob Health. 2017. PMID: 28090819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical